Skip to content
Abierto
Menu

Sources sought

RFI Novel Antimalarial Drug Targets

PANDHA-25-P-0000-015601-RFI-Novel-Antimalarial-Drug-Targets

Defense Health Agency (Dha), Army Med Res Acq Activity. Research and Development in Biotechnology (except Nanobiotechnology).

View on SAM.govMarkdown

Response deadline

May 19, 2025 at 10:00 AM EDT

Closed 487 days ago. Posted May 7, 2025. Scheduled to archive June 3, 2025.

Description

As published on SAM.gov.

This Request for Information (RFI)/Sources Sought (SS) Notice is for market research information and planning purposes only, and shall not be construed as a solicitation or as an obligation on the part of WRAIR, CIDR, VDB, or the Defense Health Agency (DHA) US Army Medical Research Acquisition Activity (USAMRAA).

This non-commercial R&D requirement is expected to be a two-year study with a straight two-year Period of Performance (PoP) beginning September 30, 2025, and ending September 29, 2027. The work to be performed under this contract shall be performed off-site at Contractor facilities that may be located anywhere in the Continental United States (CONUS). See attached Request for information With DRAFT Statement of Work.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 7, 2025

    Sources sought

    Due May 19, 2025 at 10:00 AM EDT. SAM.gov, notice b99aa7f3422c4c5b9266b318daa121f1

Points of contact

Also open from this buyer